Blog & Actualités

Insights & Actualités Tech

Découvrez nos derniers articles sur le développement web, le design et les technologies digitales qui façonnent l'avenir

Recherche pour : "EMO"
Effacer les filtres
AI models flub these intelligence tests. Can you fare any better?

AI models flub these intelligence tests. Can you fare any better?

Puzzles and games have been central to AI development since the very beginning. Just as we humans like to test our smarts with crosswords or logic puzzles, developers can test how far models have advanced with a gaming gauntlet. The term “machine learning” was popularized in a 1959 article by the...

Xbox 25 ans : Razer revisite le vert translucide

Xbox 25 ans : Razer revisite le vert translucide

Le monde du gaming est en ébullition. À l'occasion du 25ème anniversaire de la Xbox, Razer a choisi de ressusciter l'iconique vert translucide des débuts...

Bill Gates says we’ve passed AI’s danger thresholds. Now what?

Bill Gates says we’ve passed AI’s danger thresholds. Now what?

It’s a glorious day in Kirkland, Washington, an affluent Seattle suburb on the eastern shore of Lake Washington. The temperature is in the mid-80s, and the sky is incapable of being any more blue. The view from the Gates Ventures conference room overlooks the Carillon Point Marina, where a flotilla...

Gamescom 2026 : le digital au cœur du gaming

Gamescom 2026 : le digital au cœur du gaming

La Gamescom 2026, le plus grand salon européen du jeu vidéo, s'annonce comme un rendez-vous incontournable pour les passionnés et les professionnels du...

Seeing through murky waters

Seeing through murky waters

When remotely operated vehicles settle on the seafloor or dig through a sand bed, they can kick up clouds of sediment that onboard cameras struggle to see through. Often, the only thing to do is wait until the dust settles. But a new system developed by Amy Phung, SM ’23, PhD ’26, and her advisor...

Amping up T cells to target cancer

Amping up T cells to target cancer

Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening...